Pharmaceutical Technology23m
Biomea’s stock bounces back as FDA lifts clinical hold on diabetes trials
The US FDA placed a full clinical hold on two diabetes trials for Biomea’s menin inhibitor after reports of liver toxicity.
Swimming World2m
Georgia Scores First 2026 Verbal From Backstroker Virginia Hinds
Georgia Scores First 2026 Verbal From Backstroker Virginia Hinds NEW COMMIT: The University of Georgia has opened its Class ...
WFI Keeps Jaipur Nationals Medallists Out Of World Championship Trials: Report
On the other hand, the wrestlers who bagged medals at the Wrestling Federation of India-hosted Nationals in Pune, have been permitted to participate in the trials ...
Medscape26m
FDA OKs First-in-Class Antipsychotic for Schizophrenia
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.
Bristol Myers Stock Up on FDA Nod for Schizophrenia Treatment
The FDA approves BMY's differentiated schizophrenia treatment for adults and broadens its diverse portfolio. Shares gain.
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...
Ryan Murphy On His Paris Olympic Journey As U.S.A Team Captain
Interview: U.S.A. swim team captain Ryan Murphy on his Paris Olympic wins and silver lining found in the 200-meter back ...
Fred Hutch36m
Young breast cancer patient’s self-exam and self-advocacy leads to cancer diagnosis
Gillian McDonald was diagnosed with triple negative inflammatory breast cancer at age 33. Learn how she navigated her care ...
Esketamine shows promise for treatment-resistant depression
An estimated one-third of patients with major depressive disorder have treatment-resistant depression (TRD), characterized by ...
The Raw Story9m
'Looks like a coverup': Reporter rips media outlets for sitting on hacked Trump materials
The opposition research dossier compiled by Donald Trump's campaign on J.D. Vance was published online after hackers – ...
Daily23m
Timing of dosing of BP medication makes no difference, reports research
Evening administration of blood pressure (BP)-lowering medications did not reduce the risk of cardiovascular events or death ...
FDA approves 1st new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb, combines ...